Catheter-associated urinary tract infections (CAUTIs) are common hospital-acquired infections 27 and frequently polymicrobial, which complicates effective treatment. However, few studies 28 experimentally address the consequences of polymicrobial interactions within the urinary tract, 29 and the clinical significance of polymicrobial bacteriuria is not fully understood. Proteus 30 mirabilis is one of the most common causes of monomicrobial and polymicrobial CAUTI, and 31 frequently co-colonizes with Enterococcus faecalis, Escherichia coli, Providencia stuartii, and 32 Morganella morganii. P. mirabilis infections are particularly challenging due to its potent urease 33 enzyme, which facilitates formations of struvite crystals, catheter encrustation, blockage, and 34 formation of urinary stones. We previously determined that interactions between P. mirabilis and 35 other uropathogens can enhance P. mirabilis urease activity, resulting in greater disease severity 36 during experimental polymicrobial infection. Our present work reveals that M. morganii acts on 37 P. mirabilis in a contact-independent manner to decrease urease activity. Furthermore, M. 38 morganii actively prevents urease enhancement by E. faecalis, P. stuartii, and E. coli. 39 Importantly, these interactions translate to modulation of disease severity during experimental 40 CAUTI, predominantly through a urease-dependent mechanism. Thus, products secreted by 41 multiple bacterial species in the milieu of the catheterized urinary tract can directly impact 42 prognosis. 43 urolithiasis; urease 46 47
Introduction
Uropathogens exhibit comparable competitive fitness during co-culture in dilute human urine. 137 To determine if P. mirabilis exhibits cooperative or competitive behavior with E. faecalis, E. 138 coli, or M. morganii, each bacterial species was cultured independently or co-cultured in dilute 139 human urine and bacterial viability was assessed by differential plating at hourly timepoints until 140 the cultures achieved stationary phase (Figure 1 ). The viability of P. mirabilis was not 141 significantly impacted by co-culture with any of the other species ( Figure 1A) , and similar 142 results were observed for E. faecalis ( Figure 1B ) and M. morganii ( Figure 1C ), indicating that 143 these species do not exhibit competitive behavior during co-culture in vitro. In contrast, E. coli 144 viability was unaffected by M. morganii but dramatically reduced during co-culture with P. 145 mirabilis ( Figure 1D ). The reduction in viability was pH-dependent, as E. coli viability did not 146 decrease during co-culture with a P. mirabilis urease mutant (∆ure). Thus, E. coli is sensitive to 147 the increase in urine pH that occurs due to P. mirabilis urease activity, but these species do not 148 appear to exhibit any other competition in vitro. 149 
150

M. morganii prevents enhancement of P. mirabilis urease activity by other bacterial species in
151 a contact-independent manner. We previously demonstrated that numerous uropathogens, 152 including E. faecalis (Ef), P. stuartii (Ps), and E. coli (Ec), can enhance P. mirabilis (Pm) urease 153 activity during co-culture in urine while M. morganii (Mm) appears to dampen activity (47). We 154 therefore sought to determine if urease modulation by these species requires direct cell-cell 155 contact or if P. mirabilis may be responding to factors present in cell-free supernatants. An 156 example of the experimental approach is shown in Figure 2A . Briefly, each bacterial species of interest was incubated in filter-sterilized human urine for 90 minutes, centrifuged to pellet, and 158 filter-sterilized. Cell-free supernatants were also generated from co-cultures of M. morganii with 159 each of the other bacterial species for comparison to 50:50 mixtures of the monomicrobial 160 culture supernatants. In addition, cell-free supernatant was generated from an isogenic urease 161 mutant of P. mirabilis HI4320 (∆ure) for use as a control for the potential impact of nutrient and 162 cofactor depletion on total urease activity. Wild-type P. mirabilis HI4320 was then incubated in 163 each of the cell-free supernatants, and urease activity was measured over a 120-minute time that M. morganii is either able to prevent production of the enhancing signal by each of the other 181 bacterial species, or that it inactivates, sequesters, or depletes the enhancing signal from the 182 culture supernatant. In either case, M. morganii actively prevents enhancement of P. mirabilis 183 urease activity by other bacterial species, in addition to directly dampening P. mirabilis urease 184 activity. 
M. morganii prevents enhancement of P. mirabilis cytotoxicity by other bacterial species.
Our 187 prior studies with P. mirabilis and P. stuartii demonstrated that co-culture increased cytotoxicity 188 to HEK293 cells in vitro compared to monomicrobial cultures, and that this process was not 189 dependent upon urease activity from either species (47). We therefore utilized the in vitro Cytotoxicity was first compared for wild-type P. mirabilis, the isogenic urease mutant 201 (Pm ∆ure), and M. morganii ( Figure 3B ). As expected, incubation with the urease mutant 202 resulted in a similar level of cytotoxicity to HEK293 cells as wild-type P. mirabilis, confirming 203 10 that urease does not contribute to cytotoxicity under these conditions. The urease mutant was 204 therefore utilized for all further cytotoxicity experiments. Interestingly, M. morganii 205 monomicrobial cultures exhibited a similar level of cytotoxicity as P. mirabilis ∆ure, and co-206 culture had no detectable impact on total cytotoxicity ( Figure 3B ).
207
E. faecalis monomicrobial cultures also exhibited comparable cytotoxicity as P. mirabilis 208 ∆ure, but co-culture of P. mirabilis ∆ure with E. faecalis significantly increased cytotoxicity 209 over the level observed for the monomicrobial cultures as well as the predicated value for the 210 dual-species culture ( Figure 3C ). Thus, the interaction between these species appears to enhance 211 production of other virulence factors in addition to increase urease activity. However, the 212 addition of M. morganii dampened cytotoxicity back to a similar level as observed for each 213 respective monomicrobial culture ( Figure 3C ). Taken together, these results indicate that co-214 culture of P. mirabilis with E. faecalis increases cytotoxicity in a urease-independent manner, 215 and M. morganii dampens this enhancement.
216
Similarly, co-culture of P. mirabilis ∆ure with a P. stuartii urease mutant (Ps ∆ure) 217 increased cytotoxicity above the level observed for either monomicrobial culture as well as the 218 predicated co-culture level, which is consistent with our previous work (47). For this co-culture 219 condition, M. morganii was capable of dampening enhancement back down to the level observed 220 for P. mirabilis ∆ure alone, but not quite to the predicated level of activity ( Figure 3D ). In 221 contrast, co-culture of P. mirabilis ∆ure with E. coli resulted in an intermediate level of 222 cytotoxicity that was significantly greater than E. coli alone as well as the predicted value, but 223 not greater than that of P. mirabilis ∆ure alone ( Figure 3E ). However, the addition of M. 224 morganii had no discernable impact on cytotoxicity for this combination ( Figure 3E ). In 225 summary, co-culture of P. mirabilis with E. faecalis, P. stuartii, or E. coli increases cytotoxicity 226 11 to varying degrees through a urease-independent mechanism, and M. morganii is capable of 227 preventing increased cytotoxicity from E. faecalis and P. stuartii, but not E. coli. 
250
All mice exhibited weight loss during the first 24 hpi, regardless of infection group, and 251 the majority of mice failed to recover weight during the study. The only group of mice that 252 exhibited recovery from the initial weight loss were those that received an E. coli monomicrobial 253 inoculum ( Fig S 2A, C, and H) . This is likely because monomicrobial inoculation with 1x10 5
254
CFUs of E. coli resulted in the lowest bacterial burden of all of the infection groups ( Figure 5A ) 255 as well as the lowest overall infection severity (Table 1) were reduced in the presence of P. mirabilis but unaffected by E. faecalis (Fig S 4C) , and E. coli 264 CFUs were augmented by P. mirabilis (Fig S 4D ). Despite these shifts in bacterial burden for 265 each species, the total combined CFUs achieved within the urinary tract were consistent across 266 all of the polymicrobial infections ( Figure 5B ).
267
The similarities in total bacterial burden across infection groups is particularly 268 noteworthy considering that there were dramatic differences in disease severity between 269 infection groups (Table 1) . P. mirabilis exhibited the greatest disease severity of the 270 monomicrobial infections, with 78% of mice exhibiting bacteremia and 26% urolithiasis.
13
Coinfection of P. mirabilis with E. coli did not significantly impact the incidence of bacteremia 272 or urolithiasis compared to P. mirabilis monomicrobial infection, despite the ability of this 273 combination to increase urease activity and cytotoxicity in vitro. In contract, coinfection of P. 274 mirabilis with E. faecalis resulted in the most severe disease presentation, as 96% of these mice 275 exhibited bacteremia (+18% relative to P. mirabilis monomicrobial infection, p=0.054) and 56% 276 exhibited urolithiasis (+30% relative to P. mirabilis monomicrobial infection, p=0.027). This 277 coinfection combination also resulted in the greatest incidence of maximum histopathology 278 scores for tissue damage and inflammation in the bladder ( Figure 5C ) and the highest combined 279 scores for bladder and kidney damage ( Figure 5E ). Representative bladder sections are displayed 280 in Figure 5F -M, and representative kidney sections are displayed in Fig S 4 .
281
Remarkably, the addition of M. morganii to the P. mirabilis and E. faecalis coinfection 282 dramatically reduced infection severity to level that was indistinguishable from mice infected 283 with P. mirabilis alone or mice coinfected with P. mirabilis and M. morganii (Table 1) . Seventy- Modulation of polymicrobial infection severity is predominantly mediated through a urease-296 dependent mechanism. Our prior studies of P. mirabilis with P. stuartii demonstrated that 297 increased disease severity during coinfection of these species was dependent on the presence of a 298 functional urease operon in P. mirabilis and enhancement of urease activity (47, 48) . We 299 therefore tested the hypothesis that P. mirabilis urease activity is required for modulation of 300 disease severity during polymicrobial infection. Mice were inoculated as above, only using the 301 isogenic urease mutant of P. mirabilis HI4320, ∆ure. Fig S 5 shows percent weight change. mirabilis, there were no significant differences in total bacterial burden within the urinary tract 311 between infection groups ( Figure 6 ). P. mirabilis ∆ure CFUs were again largely similar across 312 all infection types (Fig S 6A) . Interestingly, E. faecalis CFUs were significantly decreased in the 313 urine and kidneys when P. mirabilis ∆ure was present (Fig S 6B) , which was not observed 314 during infection with the wild-type strain (Fig S 3D ), suggesting that E. faecalis colonization 315 may be perturbed by P. mirabilis in the absence of urease activity. M. morganii colonization was 316 again significantly decreased in the urine, bladder, and kidneys when P. mirabilis ∆ure was 317 present, indicating that the impact of P. mirabilis on M. morganii colonization is urease-318 independent (Fig S 6C) . Similarly, E. coli colonization was significantly increased when P. 319 mirabilis ∆ure was present, indicating that urease activity is not required for enhancement of E. 320 coli colonization during coinfection (Fig S 6D) .
321
Despite these differences in the colonization density achieved by each individual 322 bacterial species during co-infection, the total bacterial burden with the urinary tract again 323 remained consistent across infection groups ( Figure 6 ). Compared to monomicrobial infection 324 with wild-type P. mirabilis, ∆ure infections exhibited a significant reduction in the incidence of 325 bacteremia (40% compared to 78%, p<0.001), which is consistent with the role of urease activity 326 and urolithiasis in tissue damage and progression to bacteremia (47, 48) . Even more striking was 327 the observation that disease severity remained consistent between monomicrobial infection with 328 P. mirabilis ∆ure and each of the polymicrobial infections, in stark contrast to the results 329 obtained with wild-type P. mirabilis (Table 1) . Thus, while urease-independent interactions still 330 have the potential to influence disease severity during polymicrobial P. mirabilis CAUTI, 331 modulation of urease activity is the main contributor to infection severity in this model system.
332
The mechanism(s) by which M. morganii dampens P. mirabilis urease activity and prevents 333 enhancement by other bacterial species may therefore elucidate potent inhibitors of infection 334 severity, and could have clinical utility for CAUTIs involving P. mirabilis. interactions between bacteria within the catheterized bladder and in catheter biofilms have the 373 potential to significantly impact catheter encrustation, tissue damage, urolithiasis, and 374 dissemination to the kidneys and bloodstream.
375
The implications of our findings, in this context, are depicted in Figure 7 . When P. 376 mirabilis is present in the bladder in the absence of other bacterial species, it is capable of 377 causing stone formation, crystalline catheter biofilms, ascending to the kidneys, and potentially 378 dissemination to the bloodstream ( Figure 7A ). When an enhancing species is present, such as P. 379 stuartii, E. coli, or E. faecalis, secreted factors produced by these organisms act on P. mirabilis 380 to increase urease activity and cytotoxicity. This leads to an increase in tissue damage, urine pH 381 and crystalline deposits, and catheter encrustation and blockage, in addition to promoting 382 urolithiasis and bacteremia. Bladder co-colonization of P. mirabilis with E. coli also bolsters E. 383 coli CFUs, which may potentiate its impact on P. mirabilis ( Figure 7B ). However, when M. 384 morganii is present, it secretes factors that counteract the effects of these other microbes on P. 385 mirabilis urease activity and cytotoxicity, thereby reducing crystal formation, catheter 386 encrustation and blockage, urolithiasis, and bacteremia ( Figure 7C ). Considering the level of 387 activity present in cell-free urine supernatants of these organisms, it is likely that if any of these 388 modulatory organisms are present in the bladder, they would exert an impact on catheter-resident although only E. coli received a benefit from co-colonization in our CAUTI model. Coinfection 397 of P. mirabilis with P. stuartii has no impact on bacterial burden of either species within the 398 urinary tract, but their interactions actually promotes a potent proinflammatory response, greater 399 tissue damage, and an increased incidence of severe disease during both UTI and CAUTI (47, 400 48). This is likely also the case for coinfection of P. mirabilis with E. faecalis, given the increase 401 in cytotoxicity that occurs in vitro and the incidence of bacteremia in our CAUTI model.
402
Increased likelihood of severe disease has also been observed during coinfection of P. mirabilis 403 with Staphylococcus saprophyticus (63), and for P. aeruginosa with E. faecalis (64). Bacterial strains and growth conditions. Proteus mirabilis HI4320, Providencia stuartii 434 BE2467, and Morganella morganii TA43 were isolated from the urine of catheterized patients in 435 a chronic care facility in Maryland (12). Escherichia coli CFT073 was isolated from a patient 436 hospitalized for acute pyelonephritis (68). Enterococcus faecalis 3143 was isolated from the 437 urine of a catheterized nursing home resident in Michigan (47). P. mirabilis ∆ure refers to P. 438 mirabilis HI4320 lacking urease activity due to an insertional-disruption of the ureF gene, and P. 439 stuartii ∆ure refers to P. stuartii BE2467 lacking the portion of its plasmid that encodes the 440 urease operon (47, 69, 70) . Bacteria were routinely cultured at 37°C with aeration in 5 ml LB 441 broth (10 g/L tryptone, 5 g/L yeast extract, 0.5 g/L NaCl) or on LB solidified with 1.5% agar.
442
Enterococcus faecalis isolates were cultured in brain heart infusion (Difco) broth. LB was 443 supplemented with 25 µg/ml kanamycin, 20 µg/ml chloramphenicol, 25 µg/ml ampicillin, 2.5 444 µg/ml tetracycline, or 100 µg/ml streptomycin to distinguish between species. 
